NANOSTRING TECHNOLOGIES
LIVE

Serial Number

85105562

Owner

NanoString Technologies, Inc.

Attorney

Alyssa M. Worsham

First Use Date

Feb 18, 2008

Filing Date

Aug 11, 2010

Add to watchlist:

No watchlists yet
View on USPTO

NANOSTRING TECHNOLOGIES Trademark

Serial Number: 85105562 • Registration: 4122496

NANOSTRING TECHNOLOGIES is a trademark filed by NanoString Technologies, Inc. on August 11, 2010. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NanoString Technologies, Inc. (31 trademarks)

530 Fairview Avenue North, Suite 2000
Seattle, WA 98109

Entity Type: 03

BRUKER SPATIAL BIOLOGY, INC. (22 trademarks)

40 MANNING ROAD
BILLERICA, MA 01821

Entity Type: 03

Trademark Details

Filing Date

August 11, 2010

Registration Date

April 3, 2012

First Use Anywhere

February 18, 2008

First Use in Commerce

February 18, 2008

Published for Opposition

May 10, 2011

Goods & Services

Computer-based apparatus for detection and analysis of gene expression for use in the fields of health care and life sciences; computer-based apparatus for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and prognostic, predictive, clinical, oncology, and hematology diagnostics

Multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, including for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics, namely, medical diagnostic reagents

Multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, including for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research use, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, and diagnostic reagents for clinical or medical laboratory use

Product research and development services for others in the field of biotechnology

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 4, 2024 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 3, 2022 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 3, 2022 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 3, 2022 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 3, 2022 APRE
TEAS SECTION 8 & 9 RECEIVED
Mar 14, 2022 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 3, 2021 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 18, 2020 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 9, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 9, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 9, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 27, 2017 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 27, 2017 TCCA
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 3, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Apr 3, 2012 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Feb 29, 2012 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Feb 28, 2012 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 23, 2012 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Feb 16, 2012 SUPC
USE AMENDMENT FILED
Feb 14, 2012 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 14, 2012 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2012 EXRA
SOU EXTENSION 1 GRANTED
Feb 6, 2012 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2012 AITU
SOU EXTENSION 1 FILED
Jan 5, 2012 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 5, 2012 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 5, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2011 NPUB
PUBLISHED FOR OPPOSITION
May 10, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 5, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 5, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 5, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 5, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 5, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 5, 2011 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 4, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 1, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 23, 2011 PREV
ASSIGNED TO LIE
Mar 22, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 4, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 4, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 4, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 4, 2011 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 13, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jan 13, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jan 13, 2011 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2010 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2010 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2010 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2010 DOCK
NOTICE OF DESIGN SEARCH CODE MAILED
Aug 17, 2010 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 16, 2010 NWOS
NEW APPLICATION ENTERED
Aug 14, 2010 NWAP